Infections and Multiple Sclerosis: From the World to Sardinia, From Sardinia to the World.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2021
Historique:
received: 21 06 2021
accepted: 20 09 2021
entrez: 25 10 2021
pubmed: 26 10 2021
medline: 28 12 2021
Statut: epublish

Résumé

Multiple Sclerosis (MS) is an inflammatory disease of the central nervous system. Sardinia, an Italian island, is one of the areas with the highest global prevalence of MS. Genetic factors have been widely explored to explain this greater prevalence among some populations; the genetic makeup of the Sardinians appears to make them more likely to develop autoimmune diseases. A strong association between MS and some infections have been reported globally. The most robust evidence indicating the role of infections is MS development concerns the Epstein-Barr virus (EBV). Anti-EBV antibodies in patients once infected by EBV are associated with the development of MS years later. These features have also been noted in Sardinian patients with MS. Many groups have found an increased expression of the Human endogenous retroviruses (HERV) family in patients with MS. A role in pathogenesis, prognosis, and prediction of treatment response has been proposed for HERV. A European multi-centre study has shown that their presence was variable among populations, ranging from 59% to 100% of patients, with higher HERV expression noted in Sardinian patients with MS. The

Identifiants

pubmed: 34691035
doi: 10.3389/fimmu.2021.728677
pmc: PMC8527089
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

728677

Informations de copyright

Copyright © 2021 Frau, Coghe, Lorefice, Fenu and Cocco.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Retrovirology. 2009 Nov 16;6:104
pubmed: 19917105
J Cell Physiol. 2018 Apr;233(4):2850-2862
pubmed: 28631829
Cell. 1995 Mar 10;80(5):695-705
pubmed: 7534214
Nature. 1992 Jul 9;358(6382):155-7
pubmed: 1377368
Brain. 2011 Sep;134(Pt 9):2772-86
pubmed: 21846731
J Neuroimmunol. 2014 May 15;270(1-2):51-5
pubmed: 24642384
Ann Neurol. 2013 Nov;74(5):721-32
pubmed: 23836485
Viruses. 2017 Jun 27;9(7):
pubmed: 28653997
Trends Immunol. 2017 Jul;38(7):498-512
pubmed: 28549714
Mult Scler. 2011 Oct;17(10):1185-93
pubmed: 21685232
Sci Rep. 2016 Jun 30;6:29227
pubmed: 27356622
PLoS One. 2012;7(9):e44991
pubmed: 23028727
Retrovirology. 2014 Jan 09;11:2
pubmed: 24405691
Metab Brain Dis. 2006 Sep;21(2-3):163-9
pubmed: 16865539
Ann Neurol. 2007 Jun;61(6):504-13
pubmed: 17492755
J Neuroimmunol. 1996 Apr;65(2):143-53
pubmed: 8964896
Mult Scler. 2012 May;18(5):605-9
pubmed: 22020417
J Neurol. 2017 Mar;264(3):453-466
pubmed: 28005176
PLoS One. 2012;7(4):e33972
pubmed: 22509268
Int J Biomed Sci. 2007 Dec;3(4):292-7
pubmed: 23675056
Neurology. 2002 Oct 8;59(7):1071-3
pubmed: 12370465
BMC Neurol. 2016 Aug 23;16(1):148
pubmed: 27552900
PLoS One. 2011 Apr 13;6(4):e18482
pubmed: 21533236
Mult Scler. 2006 Jun;12(3):357-9
pubmed: 16764351
J Exp Med. 1989 Jul 1;170(1):59-71
pubmed: 2787386
Genes Immun. 2003 Jan;4(1):4-11
pubmed: 12595896
J Neurovirol. 2009 Jan;15(1):4-13
pubmed: 19039700
J Infect Dev Ctries. 2013 Mar 14;7(3):203-7
pubmed: 23492997
Mult Scler Relat Disord. 2019 Nov;36:101388
pubmed: 31525628
Mult Scler. 2014 Feb;20(2):174-82
pubmed: 23877972
Acta Neurol Scand. 1975 Feb;51(2):110-36
pubmed: 46682
Viruses. 2020 Jun 13;12(6):
pubmed: 32545816
J Invest Dermatol. 2011 Dec;131(12):2419-27
pubmed: 21776007
J Neurol Sci. 2015 Feb 15;349(1-2):249-50
pubmed: 25598492
J Clin Med. 2018 Dec 07;7(12):
pubmed: 30544526
West J Med. 1975 May;122(5):380-93
pubmed: 165638
Mol Neurobiol. 2019 Apr;56(4):2590-2605
pubmed: 30047100
Mult Scler. 2021 Aug;27(9):1332-1340
pubmed: 33566725
PLoS One. 2015 Apr 08;10(4):e0119605
pubmed: 25853421
Front Immunol. 2020 Dec 17;11:587078
pubmed: 33391262
PLoS One. 2010 Sep 01;5(9):
pubmed: 20824132
PLoS One. 2009 Nov 05;4(11):e7638
pubmed: 19890384
Nucleic Acids Res. 2013 Mar 1;41(5):2950-62
pubmed: 23358825
Circulation. 2017 Nov 14;136(20):1920-1935
pubmed: 28935667
J Neurol Sci. 2014 Dec 15;347(1-2):78-81
pubmed: 25271190
Mult Scler. 2012 Aug;18(8):1181-4
pubmed: 22261119
Cell. 1987 Sep 11;50(6):819-20
pubmed: 3621346
Ann Neurol. 2007 Apr;61(4):288-99
pubmed: 17444504
N Engl J Med. 2017 Apr 27;376(17):1615-1626
pubmed: 28445677
Neuromolecular Med. 2015 Jun;17(2):83-96
pubmed: 24652042
Sci Rep. 2016 Mar 09;6:22401
pubmed: 26956729
Ital J Neurol Sci. 1987 Jun;Suppl 6:45-50
pubmed: 2820894
J Neurovirol. 2008 Jan;14(1):73-7
pubmed: 18300077
Semin Immunol. 2013 Nov 15;25(4):305-12
pubmed: 24211039
Neurology. 2002 Feb 12;58(3):471-3
pubmed: 11839854
J Neuroimmunol. 2020 Jan 15;338:577110
pubmed: 31715457
Mult Scler. 2013 Nov;19(13):1690-1
pubmed: 24218486
Mult Scler. 2018 Jan;24(1):42-47
pubmed: 29307292
J Autoimmun. 1992 Dec;5(6):691-702
pubmed: 1489484
Curr Opin Rheumatol. 2013 Jul;25(4):496-501
pubmed: 23656710
Front Neurol. 2017 May 19;8:216
pubmed: 28579973
Neurol Sci. 2001 Apr;22(2):171-3
pubmed: 11603622
Lancet. 1998 Jan 3;351(9095):33
pubmed: 9433428
J Neuroimmunol. 2018 Oct 15;323:49-52
pubmed: 30196833
J Autoimmun. 2020 Jan;106:102332
pubmed: 31515129
Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14902-7
pubmed: 21746931
PLoS One. 2013 Apr 08;8(4):e59790
pubmed: 23593151
Curr Opin Virol. 2014 Feb;4:78-84
pubmed: 24553068
Clin Transl Immunology. 2017 Jun 16;6(6):e147
pubmed: 28748090
Sci Rep. 2017 Jun 9;7(1):3179
pubmed: 28600575
Mult Scler. 2015 Aug;21(9):1200-3
pubmed: 25480862
J Neuroimmunol. 2013 Nov 15;264(1-2):120-2
pubmed: 24099984
J Neurol Sci. 2013 Dec 15;335(1-2):131-3
pubmed: 24075312
Eur J Neurol. 2016 Jan;23(1):140-7
pubmed: 26453465
Science. 1985 Nov 29;230(4729):1043-5
pubmed: 2414848
Drug Discov Today Dis Models. 2020 Fall;32:27-33
pubmed: 32292487
Mult Scler. 2015 Jul;21(8):984-95
pubmed: 25392335
J Allergy Clin Immunol. 2017 Sep;140(3):797-808
pubmed: 28237728
PLoS One. 2013 Nov 13;8(11):e78474
pubmed: 24236019
Int J Exp Pathol. 2001 Jun;82(3):149-70
pubmed: 11488990
Mult Scler. 2017 Jul;23(8):1050-1055
pubmed: 28406354
Mult Scler. 2013 Oct;19(11):1437-42
pubmed: 23439580

Auteurs

Jessica Frau (J)

Multiple Sclerosis Centre, Azienda Tutela Salute (ATS) Sardegna, University of Cagliari, Cagliari, Italy.

Giancarlo Coghe (G)

Multiple Sclerosis Centre, Azienda Tutela Salute (ATS) Sardegna, University of Cagliari, Cagliari, Italy.

Lorena Lorefice (L)

Multiple Sclerosis Centre, Azienda Tutela Salute (ATS) Sardegna, University of Cagliari, Cagliari, Italy.

Giuseppe Fenu (G)

Multiple Sclerosis Centre, Azienda Tutela Salute (ATS) Sardegna, University of Cagliari, Cagliari, Italy.

Eleonora Cocco (E)

Multiple Sclerosis Centre, Azienda Tutela Salute (ATS) Sardegna, University of Cagliari, Cagliari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH